Evidence map›Paper›PMID 30336209›Full record

ArticleNeurobiology of learning and memory2018

Inhibiting gustatory thalamus or medial amygdala has opposing effects on taste neophobia.

Joe Arthurs, Jian-You Lin, Steve Reilly

Abstract read
In one paragraph

Article in Neurobiology of learning and memory, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Joe ArthursUniversity of Illinois at Chicago, Department of Psychology, United States. Electronic address: jarthurs@uw.edu.
Jian-You LinUniversity of Illinois at Chicago, Department of Psychology, United States.
Steve ReillyUniversity of Illinois at Chicago, Department of Psychology, United States. Electronic address: sreilly@uic.edu.

Funding

Parabrachial-Forebrain Interactions in CTAR01DC006456 · NIDCD · UNIVERSITY OF ILLINOIS AT CHICAGO · PI REILLY, STEPHEN · 2004 to 2020
$3.9M
Parabrachial-Forebrain Interactions in Conditioned Taste AversionR56DC006456 · NIDCD · UNIVERSITY OF ILLINOIS AT CHICAGO · PI REILLY, STEPHEN · 2009 to 2009
$339k
NIDCD NIH HHS R01 DC006456NIDCD NIH HHS R56 DC006456
6 · The paper itself

Abstract

Taste neophobia is a feeding system defense mechanism that limits consumption of an unknown, and therefore potentially dangerous, edible until the post-ingestive consequences are experienced. We found that transient pharmacological inhibition (induced with the GABA agonists baclofen and muscimol) of the gustatory thalamus (GT; Experiment 1), but not medial amygdala (MeA; Experiment 2), during exposure to a novel saccharin solution attenuated taste neophobia. In Experiment 3 we found that inhibition of MeA neurons (induced with the chemogenetic receptor hM4DGi) enhanced the expression of taste neophobia whereas excitation of MeA neurons (with hM3DGq) had no influence of taste neophobia. Overall, these results refine the temporal involvement of the GT in the occurrence of taste neophobia and support the hypothesis that neuronal excitation in the GT is necessary for taste neophobia. Conversely, we show that chemogenetically, but not pharmacologically, inhibiting MeA neurons is sufficient to exaggerate the expression of taste neophobia.

Indexed as

AnimalsAvoidance LearningBehavior, AnimalConditioning, ClassicalCorticomedial Nuclear ComplexGABA AgonistsGenetic TechniquesMaleRatsRats, Sprague-DawleyTaste PerceptionVentral Thalamic NucleiGABA AgonistsChemogeneticsConditioned taste aversionDREADDsPharmacological inhibitionTaste neophobia

Identifiers

PMID30336209
PMCPMC6309437

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.